Drug and pharmaceutical recalls
17747 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIGentamicin Sulfate 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIGentamicin 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIGentamicin 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIGentamicin 0.3% Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIGaba 50 mg/Mag Sulfate 50 mg/Taurine/Theanine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIFurosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIFluphenazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIEstradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIEstradiol Cypionate 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIEnrofloxacin 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIDoxapram 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIDisodium EDTA Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIDiphenhydramine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIDiclazuril 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIDextrose 50% Solution, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIDexpanthenol 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIDexamethasone Sodium Phosphate 6 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIDetomidine w/Xylazine 100 mg/mg Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIDetomidine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIDeslorelin 15 mg vial, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IICre-O-Pan Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIClenbuterol 0.03mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIChlorpromazine HCL 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IICeftiofur GM vial 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IICal-Phos 1000 Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IICalcium Gluconate 23%, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IICaco/Copper 6. 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIBuprenorphine 0.3 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIBNP/Dexamethasone Eye Ointment, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIBi mix, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief